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pacity of cells prior to reaching a critically short telomere
length, at which time processes are activated that result
in clonal replicative senescence. Consistent with this
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Transformed cells and germline cells appear to havePrior to antigenic stimulation, the precursor frequency
of T cells or B cells with receptor specificity for any an unlimited capacity to divide and proliferate, sug-
gesting that a compensatory mechanism must exist ca-given antigen is extremely low, and it is the proliferative
response to antigen that generates clonally expanded pable of avoiding the consequences of telomere short-
ening. Indeed, one such mechanism is mediated by thepopulations of effector cells as well as populations of
long-lived memory cells that are capable of additional ribonucleoprotein enzyme telomerase, a subject of in-
tensive recent experimentation (reviewed in Blackburn,clonal expansion on reencounter with the same antigen.
Thus, the ability of lymphocytes to undergo repeated 1992; Greider, 1996). The enzymatic activity termed
telomerase is capable of synthesizing terminal TTAGGGcell division is essential for effective immune function.
This review will focus on evidence suggesting that T telomeric repeats, thus extending telomere length and
compensating for loss that occurs during chromosmaland B lymphocytes, antigen-specific cellsof the immune
system, have adapted a mechanism otherwise used by replication. Recent discoveries have identified the genes
encoding two mammalian telomerase components, onemalignant cells and germline cells to extend the replica-
tive capacity necessary for lymphocyte function. a catalytic subunit that belongs to the reverse tran-
scriptase family (Harrington et al., 1997a; Meyerson etIn marked contrast to malignant cells and cells of
the germline lineage, normal somatic cells have a finite al., 1997; Nakamura et al., 1997; Nakayama et al., 1998)
and the other an RNA template component (Blasco etcapacity for cellular replication, as first demonstrated
in the seminal observation of Hayflick that human fibro- al., 1995; Feng et al., 1995), which together are sufficient
to reconstitute telomerase activity in vitro (Weinrich etblasts cultured in vitro undergo a limited number of
cell divisions before reaching a state termed replicative al., 1997) (Figure 1). In addition, a number of telomere-
binding or telomerase-binding proteins have been iden-senescence, in which further cell division cannot occur
(Hayflick, 1965). Recently, considerable attention has tified, some of which are functionally active in the regula-
tion of telomere length (Chong et al., 1995: Harringtonfocused on the possible role of telomeres and telomere
length regulation in determining the replicative capacity et al., 1997a and 1997b; Smith and de Lange, 1997; van
Steensel and de Lange, 1997; van Steensel et al., 1998).of normal somatic cells, transformed cells, and cells of
germline lineage. The telomeric ends of chromosomes This review will summarize recent experimental findings
that establish a clear relationship between telomerehave been identified as a candidate for the ªreplicative
clockº that monitors cell division and accounts for ces- length and differentiation stage in both T and B cell
lineages and demonstrate that there is stringent regula-sation of replication. Telomeres are complex DNA±
protein structures at the ends of linear chromosomes; tion of telomerase activity during T and B lymphocyte
activation. These observations are consistent with athey are composed of hexameric DNA repeats, (TTA
GGG)n in vertebrates, and a number of tolemere-associ- model in which maintenance of telomere length, medi-
ated at least in part through the activity of telomerase,ated proteins (reviewed in Blackburn, 1991; Greider,
1996). Telomeres appear to be important in maintaining may function to support the capacity of lymphocytes
for extensive clonal expansion. In addition to consider-the integrity of chromosomes, protecting against illegiti-
mate fusion events such as the formation of dicentric ing the limitations of currently available data in ad-
dressing this hypothesis, this review will discuss thechromosomes, mediating chromosomal localization in
the nucleus, and possibly in mediating selective silenc- opportunities created by recent genetic discoveries for
more direct analysis of this seminal issue.ing of subtelomeric genes (reviewed in Greider, 1996).
As proposed by Watson (Watson, 1972), the template
priming requirement of DNA polymerases results in loss T Lymphocytes
of terminal bases during lagging strand chromosomal Telomere Shortening In Vivo and In Vitro
replication, leading (in the absence of compensatory Analysis of telomere length in human peripheral blood
mechanisms) to the shortening of telomeres with each mononuclear cells reveals that telomere length decreases
cell division. As a consequence, telomere length has progressively with increasing age of the donor (Slag-
the potential of acting as a mitotic clock, reflecting the boom et al., 1994), including telomere reduction in both
CD41 and CD81 T cells with age. Telomere length de-
creases in both naive (CD45RA1) and memory (CD45RO1)³To whom correspondence should be addressed (e-mail: Richard_
Hodes@nih.gov). human CD41 T cells as a function of age at the rate of
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Figure 1. Telosome Structure
Telomeres are specialized structures at the
ends of linear chromosomes. Telomeres con-
sist of an array of highly conserved tandem
hexamer repeats, (TTAGGG)n, and telomere
binding proteins (TRF1 and TRF2). Telomerase
is a multicomponent reverse transcriptase,
with three telomerase-associated genes iden-
tified (hTERT, hTP-1, hTR).
approximately 33 base pairs (bp) per year (Weng et al., contention that CD41 T cells undergo clonal exhaustion
1995). Strikingly, naive CD41 T cells have longer telo- in HIV patients. (However, these studies do not exclude
meres than those of memory T cells from the same the possibility that CD41 T cells in HIV patients are pre-
individual, suggesting that differentiation from naive to dominantly a new cohort of cells recently derived from
memory cells reflects cell division in vivo; the difference stem cellswith long telomeres.) In contrast to thebehav-
in telomere length in naive and memory cells is remark- ior of CD41 T cells, telomeres in CD81 T cells from HIV1
ably consistent (1.4 6 0.1 kb) at all ages, suggesting that donors are shortened relative to HIV2 donors (Effros
the differentiation of naive to memory T cells involves a et al., 1996; Palmer et al., 1997), suggesting that HIV
relatively constant number of cell divisions independent infection is associated with some alterations in the dy-
of the donor's age. A similar difference in telomere namics of T cell subpopulations. In other disorders, ac-
length is also observed in comparisons of human CD81 celerated telomere loss has been reported in lymphocytes
T cell subsets with CD282CD81 T cells, which may be from individuals with Down's syndrome (Vaziri et al.,
derived from CD281CD81 T cells, exhibiting shorter telo- 1993) and ataxia telangiectasia (Metcalfe et al., 1996),
meres than CD281CD81 T cells (Monteiro et al., 1996). suggesting that telomere loss may somehow relate to
Collectively, these results suggest that telomere length the immune dysfunction in these disorders.
may correlate with the replicative history of T cellsduring Although telomeres from human and from the mouse
in vivo activation and/or differentiation. species Mus musculus and Mus spretus all consist of
Previous studies of human fibroblasts indicated that (TTAGGG)n repeats, these species differ in the average
telomere shortening during in vitro culture correlates length of their telomeres. Telomeric restriction frag-
with the induction of replicative senescence and have ments (TRF) from M. musculus have mean lengths of
been interpreted to suggest that telomere shortening is 25±150 kb, whereas M. spretus have mean TRF lengths
in fact causally related to senescence (Harley et al., similar to those in human (5±15 kb) (Kipling and Cooke,
1990; Hastie et al., 1990). A similar phenomenon occurs 1990). Changes in telomere length with age or in vitro
during culturing of human lymphocytes (Vaziri et al., culture have generally not been detected in M. musculus
1993). When CD41 naive and memory T cells are grown somatic cells, perhaps reflecting the difficulty in de-
in vitro by stimulating with immobilized anti-CD3 1 anti-
tecting small changes in the large telomeres of this spe-
CD28 MAbs, naive T cells are capable of substantially
cies. For this reason several studies have examined telo-
more extensive division than memory T cells before
mere length with in vivo aging and in vitro culture for
reaching replicative senescence (Weng et al., 1995), a
shorter M. spretus telomeres (Prowse and Greider, 1995;difference that corresponds to a 128-fold greater repli-
Coviello-McLaughlin and Prowse, 1997). These studiescative capacity in naive CD41 T cells. Telomeres shorten
have demonstrated that telomeres of early passage M.at a rate of 50±100 bp per mean population doublings
spretus fibroblasts shorten with in vitro culture in the(MPD) for both naive and memory T cell subsets.
absence of detectable telomerase activity. At approxi-Recently, it was proposed that depletion of CD41 T
mately 60 population doublings (PD) the fibroblast linescells occuring during HIV infection reflects the destruc-
appear toundergo crisis as characterized by phenotypiction and ultimate replicative exhaustion of the CD41 T
changes, after which the cell lines express telomerasecell lineage (Ho et al., 1995). If such clonal exhaustion
and their telomere lengths stabilize. Significant telomereand senescence occurs, it might be reflected in a critical
shortening is detected in vivo as a function of age in M.level of telomere shortening in CD41 cells from HIV-
spretus spleen and brain but not in several other tissues.infected donors. In contrast to this prediction, it was
No more specific analysis of lymphoid tissues has beenfound that CD41 T cells from HIV1 donors have telo-
reported in mice or othernonhuman species. The poten-meres that are equal to or slightly longer than those
tial for analyzing telomere length regulation during de-from HIV2 donors (Wolthers et al., 1996; Palmer et al.,
fined developmental events or immune responses has1997). Consistent with these findings, the replicative
therefore not yet been fully realized in animal modelcapacity of CD41 cells from HIV1 patients is undimin-
ished (Palmer et al., 1997), which fails to support the systems.
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Figure 2. Telomerase Expression in Human T Cell Lineage Development and Activation
T lymphocytes derive from bone marrow stem cells, differentiate in the thymus, and migrate and circulate in the periphery. Telomerase activity
was measured in the course of T cell development and activation. The number of pluses reflects the relative levels of telomerase activity.
Telomerase expression resistant pathway of telomerase induction in combina-
tion with CD3-mediated signals. These results identifyUntil recently, it was proposed that telomerase is ex-
pressed ingermline and malignantcellsbut not in normal proximal signaling events that are required for telo-
merase induction in response to stimulation throughsomatic cells (Shay and Wright, 1996). However, a num-
ber of studies have tested the possibility that lympho- CD3/CD28. However, it is not clear whether these re-
quirements are specific for telomerase regulation or arecytes might use the expression of telomerase as an
adaptive strategy for extension of their replicative ca- linked to cell cycling events in general.
Although a number of human telomerase componentspacity and have found that telomerase can beexpressed
at high levels in both T and B cells. Indeed, telomerase have been identified, only one component, telomerase
RNA template (hTR), has been analyzed in T cells (Wengexpression in T and B cells is highly regulated, as it is,
for example, during T cell development in the thymus. et al.,1997a). hTR is ubiquitously expressed inall tissues
tested regardless of the status of telomerase activityHigh levels of telomerase activity are detected in the
CD4282, CD4181, and CD4182 subsets of human thy- (Feng et al., 1995). However, levels of hTR are higher in
thymocytes than in peripheral blood T cells, and in vitromocytes, with intermediate levels in CD4281 thymo-
cytes (Weng et al., 1996) (Figure 2). Low or undetectable activation of peripheral blood CD41 T cells leads to a
significant, albeit modest, 2- to 5-fold up-regulation oflevels of telomerase are expressed in mature peripheral
blood T cells, and higher levels in tonsil T cells, sug- hTR expression (Buchkovich and Greider, 1996; Weng
et al., 1997a). Thus, hTR expression is regulated to somegesting that telomerase may be induced in mature T
cells in response to antigenic stimulation (Broccoli et degree in normal T cell development and activation,
correlating with telomerase activity in these T cells. Ital., 1995; Hiyama at al., 1995; Buchkovich and Greider,
1996; Igarashi and Sakaguchi, 1996; Weng et al., 1996). will be important to analyze during T cell development
and activation expression of other telomerase genes,Telomerase is induced in peripheral blood CD41 T cells
stimulated in vitro with anti-CD3, anti-CD3 1 anti-CD28, such as hTERT, the expression of which is highly regu-
lated in germline and malignant cells. A more completeor PMA/ionomycin. Interestingly, the ability of stimuli to
induce telomerase in T cells in vitro is closely correlated understanding of telomerase gene expression should
shed light on how telomerase activity is regulated inwith the ability of stimuli to induce entry into cell cycle
(Buchkovich and Greider, 1996; Weng et al., 1996). Al- normal cells and should provide a basis for futureexperi-
mental interventions designed to modify telomerase ac-though induction of telomerase in peripheral blood T
cells requires that these predominantly quiescent G0 tivity.
Telomerase expression has also been examined incells enter cell cycle, telomerase activity once induced
does not appear to be restricted to a particular cell cycle HIV-infected individuals. As discussed above, there is
no significant decrease in telomere length in CD41 Tphase (Weng et al., 1996). Anti-CD3/CD28-induced telo-
merase expression in CD41 T cells requires new RNA cells from HIV1 donors (Wolthers et al., 1996; Palmer et
al., 1997). Thus, if there is an excessive proliferation ofand protein synthesis and requires signals mediated via
protein tyrosine kinases (Weng et al., 1996). Cyclosporin lymphocytes in HIV-infected individuals (Ho et al., 1995),
the absence of telomere shortening could result fromA (CsA) completely blocks telomerase induction in CD41
T cells stimulated with anti-CD3 alone or with PMA/ activation of telomerase in vivo in HIV-infected individu-
als. However, when telomerase activity was analyzed inionomycin, but it only partially blocks induction in T cells
that had been stimulated with anti-CD3 1 anti-CD28. CD41 and CD81 T cells from HIV-discordant monozy-
gous twins ex vivo and after in vitro stimulation, noThus, CD28-mediated signals are critical for a CsA-
Immunity
154
Figure 3. Telomere Lengthening and Telo-
merase Activation during Human B Cell Dif-
ferentiation In Vivo
Telomere length increases from naive to GC B
cells, and telomerase activity is dramatically
enhanced in GC B cells. No obvious net loss
of telomere occurs during the differentiation
process from naive to memory B cells. The
number of pluses reflects the relative levels
of telomerase activity.
significant difference was found either in thebasal levels and might in principal modulate immune responses by
or in induced telomerase activity in CD41 and CD81 T extending the replicative capacity of antigen-activated
cells from HIV1 or HIV2 monozygotic twins (Palmer et T cells (Hathcock et al., 1998). Telomerase is also acti-
al., 1997). vated in vivo in response to antigen-specific stimulation,
The relationship between telomere length regulation coincident with the clonal expansion that follows anti-
and telomerase expression in human lymphocytes has gen-specific challenge (Hathcock et al., 1998). These
been further studied in experiments that measured telo- findings indicate that induction of telomerase occurs in
mere length and telomerase activity in parallel during T cells during immune responses in vivo and may medi-
long-term stimulation of T cells. Stimulation of T cells ate a physiologic function in this setting.
induces both a rapid initial increase and a high peak
level of telomerase activity. However, the magnitude B Lymphocytes
and duration of telomerase activity decreases in long- Telomere Length Dynamics
term cultures with time and decreases with every subse- During B cell differentiation in secondary lymphoid or-
quent stimulation. Strikingly, telomere shortening is not gans, naive B cells undergo substantial cell division and
detected early after initial stimulation, when population clonal expansion in the course of differentiating into
doubling is extensive, but when telomerase activity is germinal center (GC) B cells and then memory B cells
highest. At the later phases of long-term culture, when (Kelsoe, 1996). If cell division and an accompanying loss
telomerase activity is significantly diminished, acceler- of telomeres occurs during this differentiation, it would
ated telomere reduction appears to occur. Similar pat- be expected that telomeres would be longest in naive
terns are observed in long-term cultures of human CD41 B cells and shorter in the GC and memory B cell popula-
and CD81 T cells (Bodnar et al., 1996; Weng et al., tions. Unexpectedly, however, telomeres are longer in
1997b). Thus, the relationship of telomere shortening to
human tonsil GC B cells than in naive and memory B
population doubling appears to be more complex in
cells (Weng et al., 1997c) (Figure 3). Thus, it appears that,
telomerase-expressing T lymphocytes than in human
in contrast to telomere shortening that occurs during
fibroblasts, which have no detectable telomerase activ-
conversion of naive to memory CD41 T cells, telomereity and in which telomere shortening appears to be a
length is significantly increased during differentiation ofmore constant function of population doubling. These
naive B cells into descendent GC Bcells. This representsfindings suggest, but do not directly demonstrate, that
a potentially novel indication that telomere elongationtelomere length in activated CD41 and CD81 T cells
can occur in normal somatic cells and should lead tomay be stabilized by high levels of telomerase that are
examination of the compensatory mechanisms that op-induced in these cells and may serve to prolong the
erate to elongate telomeres in GC B cells. Unfortunately,capacity for extensive clonal expansion that is critical
the lack of effective culture systems for long-term main-to physiologic T cell function.
tenance of proliferating normal B cells has precludedIn the mouse, high levels of telomerase activity are
analysis of telomere length during replication of non-expressed in hematopoietic stem cells isolated from
transformed B cells. However, telomere length reductionbone marrow and fetal liver (Blasco et al., 1995; Chade-
occurs with cell division in telomerase positive Epstein-neau et al., 1995; Prowse and Greider, 1995; Morrison
Barr virus (EBV)-infected B cells at a rate similar to thatet al., 1996). Telomerase expression is also detected in
observed in T cells cultured in vitro (100 6 20 bp/MPD)lymphoid organs including spleen and thymus (Prowse
(Guerrini et al., 1993; Counter et al., 1994).and Greider, 1995; Chadeneau et al., 1995; Blasco et al.,
Telomerase Expression1997; Ogoshi et al., 1997). As was observed for human
Like T cells, quiescent B cells isolated from peripheralT cell populations, stimulation of mouse T cells with
blood express low to undetectable levels of telomerasemitogens or with anti-TCR MAbs results in induction of
(Norrback et al., 1996). Expression of telomerase istelomerase activity (Ogoshi et al., 1997). In potentially
highly regulated during activation and differentiation ofmore physiologic responses to antigen-specific stimula-
mature human B cells that occurs in GC in vivo andtion, in vitro induction of telomerase activity is depen-
provides a mechanism for the observed increase in telo-dent upon bothTcR and CD28/B7 costimulatory signals,
mere length in GC B cells. In human tonsil B cell subsets,requirements that parallel those for induction of T cell
telomerase is low to undetectable in phenotypically na-proliferation, suggesting that telomerase activity is in-
duced in activated T cells coincident with proliferation ive B cells, becomes detectable at low levels during the
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transition from naive to GC cells, and reaches high levels germline deletion of the mouse telomerase RNA gene,
allowing for the first time a direct examination of thein GC centroblasts and centrocytes, then falling back
to low levels in memory B cells (Norrback et al., 1996; role of telomerase function in vivo (Blasco et al., 1997;
Lee et al., 1998). Mice bred as homozygous telomerase-Hu et al.,1997; Wenget al., 1997c) (Figure 3).The expres-
sion pattern of telomerase during B cell differentiation deficient animals exhibited gradual telomere shortening
in embryonic fibroblasts with each generation, with little,is intriguing in view of the observation that the longest
telomeres are found in GC B cells, the same subset in if any, expressed phenotype detected in these mice
for the first several generations of breeding, perhapswhich telomerase activity is highest, suggesting that
telomerase may actually elongate telomeres in GC B because of the initially long telomeres present in the
M. musculus mice studied. In later mouse generations,cells to preserve the replicative lifespan of progeny
memory B cells. somatic cells from these mice showed progressive telo-
mere shortening accompanied by increased aneuploidyTelomerase activity is regulated in B cells, as it is in
T cells, by signals mediated through a number of cell and chromosomal abnormalities. By generation 6 (G6),
these mice show evidence of impaired reproductivesurface receptors. Telomerase is induced in human ton-
sil naive and memory B cells stimulated in vitro by the function associated with decreased germ cell produc-
tion, decreased hematopoietic stem cell colony-formingmitogen Staphylococcus aureus Cowan strain (SAC) or
by engagement of the B cell receptor (BCR) in combina- capacity, and a decreased in vitro proliferative response
of spleen cells to stimulation with Con A, PMA 1 iono-tion with additional signals, such as anti-IgM 1 anti-
CD40, or anti-IgM 1 rIL-4 (Igarashi and Sakaguchi, 1997; phore, or anti-CD3 1 anti-CD28 (Lee et al., 1998). When
compared to activated spleen cells from control mice,Weng et al. 1997c). These stimulation conditions also
result in B cell proliferation. Stimulation with anti-CD40, activated cells from G6 telomerase-deficient mice had
equivalent proportions of cells in [G2, S, M] phases of therIL-4 alone, or anti-CD40 1 rIL-4, conditions that do
not induce significant proliferation, fail to induce te- cell cycle, but an increased proportion of these activated
cells were apoptotic. Despite impaired proliferative re-lomerase. Treatment of naive and memory tonsil B cells
with either dexamethasone or g-irradiation, conditions sponses to mitogenic and TCR-specific stimulation, his-
tological and flow cytometric analysis of bone marrow,which induce apoptotic death of B cells, also fail to up-
regulate telomerase activity (Weng et al., 1997c). Thus, spleen, and thymus from the G6 telomerase-deficient
mice did not differ from wild-type controls. G5 te-these data suggest that telomerase can be induced by
signals that induce proliferation and survival (Mandal lomerase-deficient mice that were immunized in vivo
and challenged with Listeria monocytogenes had sur-and Kumar, 1997) but not by apoptotic signals. This
linkage of telomerase expression to the induction of vival and recovery rates similar to controlmice, evidence
of a normal and effective memory response.proliferation is again consistent with an adaptive and
compensatory role in preserving the proliferative capac- Recently, it has been demonstrated that transfection
of telomerase-negative human fibroblast or epitheliality of clonally expanding B cells.
When hTRexpression was examined in B cell subsets, cell lines with the gene encoding the telomerase cata-
lytic component results in expression of telomerase ac-it was found that levels of hTR expression are approxi-
mately 2-fold higher in GC B cells than in naive and tivity by these cells (Bodnar et al., 1998). In addition,
these cells exhibit substantial increases in replicativememory B cells and are increased 2- to 3-fold in naive
and memory B cells after SAC treatment (Weng et al., capacity as well as telomere length. Manipulations such
as this may also be applicable to cells of the immune1997c). The high expression in GC B cells is further
confirmed by in situ hybridization (Yashima et al., 1997). system, allowing an analysis of telomerase function in
maintenance of telomere length or through other as yetThese results suggest that hTR is regulated and may
contribute to overall activity of telomerase in B cells, unappreciated functions of this unique enzyme.
although the magnitudes of observed differences in hTR
expression are generally much less than the corre-
Conclusionsponding differences in telomerase activity.
Recent studies have established that telomere length is
altered during differentiation of both T and B lympho-
cytes. There exists a clear and strong correlation ofExperimental Modification of Telomerase
Activity and Telomere Length replicative capacity with telomere length in normal so-
matic cells. In human T cells, this correlation extendsObserved correlations between telomere length or te-
lomerase activity and developmental stage or activation to differences in telomere length and replicative capacity
in subsets such as naive and memory CD4 cells, orstate are consistent with the hypothesis that telomere
length and telomerase enzymatic activity play a func- CD282positive and negative CD8 T cells. In addition,
telomerase, a unique reverse transcriptase that is capa-tional role in the immune system. Conditions which in-
duce proliferation of B or T cells induce expression of ble of extending telomeric length, is highly regulated
during development and activation of both T and B lym-telomerase, which may serve to slow the rate of telomere
shortening. Maintenance of telomere length may in turn phocytes. Together, these findings have provided a ba-
sis for hypotheses linking telomere length regulation toconserve the residual capacity for further cell division.
More definitive testing of this hypothesis will require a functional role in sustaining the capacity for extensive
clonal expansion in antigen-specific lymphocytes. In ad-experiments that directly manipulate telomere length
and telomerase activity. To this end, a telomerase defi- dition to providing insights into basic immune function,
manipulation of telomere length has potential therapeuticcient mouse (mTR2/2) has recently been derived by
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C.P., Adama, R.R., Chang, E., Allsopp, R.C., Yu, J., et al. (1995). Theapplications as well. For example, the ability to extend
RNA component of human telomerase. Science 269, 1236±1241.the replicative capacity of cells such as hematopoietic
Greider, C.W. (1996). Telomere length regulation. Annu. Rev. Bio-stem cells or mature lymphocytes through telomerase
chem. 65, 337±365.induction by transfection could be critical to therapeutic
Guerrini, A.M., Camponeschi, B., Ascenzioni, F., Piccolella, E., andapproaches to adoptive cell transfer or reconstitution.
Donini, P. (1993). Subtelomeric as well as telomeric sequences are
In assessing the feasibility of such approaches, it will lost from chromosomes in proliferating B lymphocytes. Hum. Mol.
be critical not only to measure extension of the capacity Genet. 2, 455±460.
for cell division but also to consider other possible con- Harley, C.B., Futcher, A.B., and Greider, C.W. (1990). Telomeres
sequences such as enhanced susceptibility to malig- shorten during ageing of human fibroblasts. Nature 345, 458±460.
nant transformation through dysregulated telomerase Harrington, L., Zhou, W., McPhail, T., Oulton, R., Yeung, D.S., Mar,
activity. Conversely, the proposed use of telomerase V., Bass, M.B., and Robinson, M.O. (1997a). Human telomerase con-
tains evolutionarily conserved catalytic and structural subunits.inhibition as a modality for anticancer therapy should
Genes Dev. 11, 3109±3115consider the possible impact of such intervention on
Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Bass, M.B.,any telomerase-dependent aspectsof immune function.
Arruda, I., and Robinson, M.O. (1997b). A mammalian telomerase-The rapid pace of gene discovery and genetic engi-
associated protein. Science 275, 973±977.
neering, in combination with a richness of available sys-
Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green,tems for studying immune cell biology, should allow
D.K., and Allshire, R.C (1990). Telomere reduction in human colo-
vigorous pursuit of these remaining questions. rectal carcinoma and with ageing. Nature 346, 866±868.
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